Carron, C P <br/><br/>
A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy.  [electronic resource] 

 -  Cancer research  May 1998 
 - 1930-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Division--drug effects<br/>Cells, Cultured<br/>Corneal Neovascularization--chemically induced<br/>Dose-Response Relationship, Drug<br/>Endothelium, Vascular--cytology<br/>Fibroblast Growth Factor 2<br/>Humans<br/>Hypercalcemia--drug therapy<br/>Leydig Cell Tumor--drug therapy<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, SCID<br/>Neoplasm Transplantation<br/>Phenylpropionates--pharmacology<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Vitronectin--antagonists & inhibitors<br/>Severe Combined Immunodeficiency--drug therapy